Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
mta angelus
- Development stage
- Unknown
- Lead developer
- Angelus Indústria de Produtos Odontológicos
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Dental
01
Overview
MTA Angelus is a mineral trioxide aggregate (MTA) cement used primarily in endodontic dentistry for root repair and related procedures. It is a calcium silicate-based bioceramic material that sets rapidly (within approximately 15 minutes), forming a stable barrier with high radiopacity and biocompatibility. The main components are Portland cement and bismuth oxide for radiopacity. Its mechanism of action involves the release of calcium ions, which promotes the formation of mineralized tissue and biological sealing of perforations, as well as inducing neoformation of periradicular cementum. MTA Angelus is indicated for use in cases such as root canal lateral and furcation perforations, internal resorption, reverse root filling (retrograde filling), pulp capping, pulpotomy, apexification, and apexogenesis[1][5][7][9]. It has lower cytotoxicity compared to some alternatives and provides an alkaline environment conducive to healing[3]. Developed by Angelus Dental Solutions in Brazil.
- Brand names
- MTA Angelus
- Other names
- MTA-AngelusMineral Trioxide Aggregate AngelusMTA Angelus Reparative Cement
Beyond the preview
Go deeper on mta angelus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on mta angelus.